Slide 1

TREATMENT STRATEGIES IN SPECIALCONDITIONSDiabetes Mellitus

TREATMENT STRATEGIES IN SPECIALCONDITIONSMetabolic Syndrome

TREATMENT STRATEGIES IN SPECIALCONDITIONSObstructive sleep apneu

TREATMENT STRATEGIES IN SPECIALCONDITIONSNephropathy

TREATMENT STRATEGIES IN SPECIALCONDITIONSCerebrovascular Disease

TREATMENT STRATEGIES IN SPECIALCONDITIONSHeart DiseaseCADHFAFLVH

TREATMENT STRATEGIES IN SPECIALCONDITIONSHeart DiseaseCADHFAFLVH

TREATMENT STRATEGIES IN SPECIALCONDITIONSAtherosclerosisArteriosclerosisPeripheral Artery Disease

TREATMENT STRATEGIES IN SPECIALCONDITIONSSexual Dysfunction

TREATMENT STRATEGIES IN SPECIALCONDITIONSResistant Hypertension

TREATMENT STRATEGIES IN SPECIALCONDITIONSMalignant Hypertension

TREATMENT STRATEGIES IN SPECIALCONDITIONSHypertensive emergencies and urgencies

TREATMENT STRATEGIES IN SPECIALCONDITIONSPerioperative Management of Hypertension

TREATMENT OF RISK FACTOR ASSOCIATED WITH HYPERTENSION

Follow UpFollow-up of hypertensive patientsFollow-up of subjects with high normalblood pressure and white-coat hypertensionElevated blood pressure at control visitsContinued search for asymptomatic organdamageCan antihypertensive medications bereduced or stopped?

Sensitivity to detect treatment-induced changes, time to change and prognostic value of change by markers of asymptomatic Organ Damage